According to the business intelligence report titled ‘Rhinoplasty Implants Market Size By Procedure (Surgical {Open Rhinoplasty, Closed Rhinoplasty}, Non-surgical), By Gender (Female, Male), By End-use (Hospitals, Ambulatory Surgical Centers), COVID19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, global rhinoplasty implants market is projected to accrue significant returns between 2021-2027.
 

As per the report findings, growing beauty consciousness among people, rising body dissatisfaction, and increasing affordability of cosmetic procedures are the key factors spurring global rhinoplasty implants market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3976588/
 

Notably, the ongoing covid-19 pandemic has promoted the work-from-home culture and subsequently led to a spike in number of online meetings sessions. This has increased the time people spend on video calls and resulted in a phenomenon called zoom dysmorphia, wherein one has continued dissatisfaction with personal appearance, prompting them to opt for facial treatments.
 

Besides, age related changes such as in nose size is driving rhinoplasty surgery demand among people aged between 30-50 years. Furthermore, the report cites that while the demand for cosmetic procedures to enhance functionality of nose and facial features is increasing, a shortage of skilled professionals is poised to act as a challenge.
 

Based on procedure, worldwide rhinoplasty implants industry is divided into non-surgical, and surgical (closed rhinoplasty, open rhinoplasty). Among these, the non-surgical segment was valued at USD 480 million in 2020 and is anticipated to expand at 16.1% CAGR between 2021-2027. High efficacy in providing enhanced outcomes, and better availability of dermal fillers can be credited for this growth.
 

Speaking of gender, the business sphere is bifurcated into male and female, among which, the latter segment amassed USD 585 million in 2020 and is estimated to grow at 16.1% CAGR over the forecast timeframe. Growing awareness about nose reshaping procedures is attributed to this expansion.
 

Moving on to the end user spectrum, the business sphere is fragmented into ambulatory surgical centers, hospitals, and others. The ambulatory surgical centers segment accrued USD 291 million in 2020 and is speculated to proliferate at 15.9% CAGR between 2021-2027. Lower treatment costs and technological advancements in aesthetic procedures are the key factors augmenting this segment’s growth.
 

Regionally speaking, Middle East & Africa held significant part of global rhinoplasty implants market share in 2020 and amassed USD 39 million in revenue. The MEA market is anticipated to grow at 14.4% CAGR between 2021-2027 due to growing beauty conscious population.
 

Key players profiled in the report are Sinclair Pharma plc, Implantech Associates Inc., Prollenium Medical Technologies Inc., Koken Co. Ltd., Croma Pharma GmbH, Surgiform Technologies LLC, Luminera Ltd., Guangzhou Wanhe Plastic Materials Co. Ltd., Anika Therapeutics Inc., W.L. Gore & Associates Inc., Stryker Corporation, and Galderma S.A.